特刊：“神经退行性疾病：最新进展与未来展望”
Special Issue: "Neurodegenerative Diseases: Recent Advances and Future Perspectives".
作者信息
López-Cuenca Inés, De Hoz Rosa
机构信息
Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, 28040 Madrid, Spain.
Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
出版信息
Biomedicines. 2024 May 13;12(5):1080. doi: 10.3390/biomedicines12051080.
Abstract
Neurodegenerative diseases include a heterogeneous group of conditions that pose a growing challenge to public health and the scientific community [...].
摘要
神经退行性疾病包括一组异质性病症，这些病症对公共卫生和科学界构成了日益严峻的挑战[……]。
相似文献
1
Special Issue: "Neurodegenerative Diseases: Recent Advances and Future Perspectives".
Biomedicines. 2024 May 13;12(5):1080. doi: 10.3390/biomedicines12051080.
2
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
3
Preface for the special issue on recent advances and future perspectives of new drug development and therapeutics on cardiovascular diseases.
Arch Pharm Res. 2019 Mar;42(3):193-194. doi: 10.1007/s12272-019-01144-x.
4
Public Health Students' Perspectives on the Future of Public Health Education.
Health Educ Behav. 2023 Aug;50(4):461-464. doi: 10.1177/10901981231179506.
5
Special Issue "Flavonoids and Their Disease Prevention and Treatment Potential": Recent Advances and Future Perspectives.
Molecules. 2020 Oct 16;25(20):4746. doi: 10.3390/molecules25204746.
6
Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.
Brain Sci. 2020 Sep 11;10(9):633. doi: 10.3390/brainsci10090633.
7
Neurodegenerative disease: models, mechanisms, and a new hope.
Dis Model Mech. 2017 May 1;10(5):499-502. doi: 10.1242/dmm.030205.
8
Public health perspectives in cross-system practice: past, present and future.
Indian J Med Ethics. 2015 Jul-Sep;12(3):131-6. doi: 10.20529/IJME.2015.041. Epub 2015 Jun 9.
9
Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
Scand J Work Environ Health. 2018 Jul 1;44(4):436-438. doi: 10.5271/sjweh.3746.
10
Focus on neurodegenerative disease.
Nat Neurosci. 2018 Oct;21(10):1293. doi: 10.1038/s41593-018-0250-x.
本文引用的文献
1
OCT Imaging in Murine Models of Alzheimer's Disease in a Systematic Review: Findings, Methodology and Future Perspectives.
Biomedicines. 2024 Feb 27;12(3):528. doi: 10.3390/biomedicines12030528.
2
Dynamic Pupillary Response in Multiple Sclerosis Patients with and without Optic Neuritis.
Biomedicines. 2023 Dec 17;11(12):3332. doi: 10.3390/biomedicines11123332.
3
An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways.
Biomedicines. 2023 Oct 24;11(11):2878. doi: 10.3390/biomedicines11112878.
4
Systematic Screening of Associations between Medication Use and Risk of Neurodegenerative Diseases Using a Mendelian Randomization Approach.
Biomedicines. 2023 Jul 7;11(7):1930. doi: 10.3390/biomedicines11071930.
5
Climate change and neurodegenerative diseases.
Environ Res. 2021 Oct;201:111511. doi: 10.1016/j.envres.2021.111511. Epub 2021 Jun 12.
6
Biomarkers for neurodegenerative diseases.
Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.
7
Alzheimer's Disease: Pathogenesis and Therapeutic Interventions.
Curr Aging Sci. 2022;15(1):2-25. doi: 10.2174/1874609814666210302085232.
8
Ageing as a risk factor for neurodegenerative disease.
Nat Rev Neurol. 2019 Oct;15(10):565-581. doi: 10.1038/s41582-019-0244-7. Epub 2019 Sep 9.
9
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a033118. doi: 10.1101/cshperspect.a033118.
Zotero 插件